| 1 | ribosome assembly (GO:0042255) | 6.06876020 |
| 2 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.39276590 |
| 3 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 5.06246260 |
| 4 | nuclear pore complex assembly (GO:0051292) | 4.80745624 |
| 5 | pore complex assembly (GO:0046931) | 4.12238988 |
| 6 | nuclear pore organization (GO:0006999) | 4.06459595 |
| 7 | establishment of integrated proviral latency (GO:0075713) | 3.98305251 |
| 8 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.56614472 |
| 9 | mitotic metaphase plate congression (GO:0007080) | 3.55617655 |
| 10 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.54852397 |
| 11 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.54465335 |
| 12 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.46822782 |
| 13 | positive regulation of immune response to tumor cell (GO:0002839) | 3.44972526 |
| 14 | regulation of immune response to tumor cell (GO:0002837) | 3.44972526 |
| 15 | regulation of response to tumor cell (GO:0002834) | 3.44972526 |
| 16 | positive regulation of response to tumor cell (GO:0002836) | 3.44972526 |
| 17 | proteasome assembly (GO:0043248) | 3.42912121 |
| 18 | rRNA modification (GO:0000154) | 3.42685814 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.38460566 |
| 20 | negative regulation of ligase activity (GO:0051352) | 3.38460566 |
| 21 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.37562012 |
| 22 | ribosome biogenesis (GO:0042254) | 3.36860532 |
| 23 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35618425 |
| 24 | cell adhesion mediated by integrin (GO:0033627) | 3.35524688 |
| 25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.30395300 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.29267227 |
| 27 | establishment of viral latency (GO:0019043) | 3.26744698 |
| 28 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.24128411 |
| 29 | metaphase plate congression (GO:0051310) | 3.22263024 |
| 30 | regulation of translational termination (GO:0006449) | 3.20388987 |
| 31 | non-recombinational repair (GO:0000726) | 3.12573120 |
| 32 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.12573120 |
| 33 | ER overload response (GO:0006983) | 3.11780754 |
| 34 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.08074316 |
| 35 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.08074316 |
| 36 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.08074316 |
| 37 | protein localization to microtubule (GO:0035372) | 3.07924737 |
| 38 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.07025146 |
| 39 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.07025146 |
| 40 | rRNA methylation (GO:0031167) | 3.04885732 |
| 41 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.04684270 |
| 42 | maturation of 5.8S rRNA (GO:0000460) | 3.04649991 |
| 43 | mitotic sister chromatid cohesion (GO:0007064) | 3.04160239 |
| 44 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.03255915 |
| 45 | regulation of chronic inflammatory response (GO:0002676) | 3.02531278 |
| 46 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.01629964 |
| 47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.01629964 |
| 48 | COPI coating of Golgi vesicle (GO:0048205) | 3.01467162 |
| 49 | Golgi transport vesicle coating (GO:0048200) | 3.01467162 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97618408 |
| 51 | establishment of chromosome localization (GO:0051303) | 2.96956928 |
| 52 | positive regulation of ligase activity (GO:0051351) | 2.96820771 |
| 53 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.95948774 |
| 54 | tRNA aminoacylation for protein translation (GO:0006418) | 2.94643174 |
| 55 | amino acid activation (GO:0043038) | 2.93283399 |
| 56 | tRNA aminoacylation (GO:0043039) | 2.93283399 |
| 57 | COPII vesicle coating (GO:0048208) | 2.85085594 |
| 58 | regulation of centriole replication (GO:0046599) | 2.84358531 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84017625 |
| 60 | formation of translation preinitiation complex (GO:0001731) | 2.83597984 |
| 61 | protein localization to chromosome, centromeric region (GO:0071459) | 2.77826118 |
| 62 | membrane raft organization (GO:0031579) | 2.75894781 |
| 63 | mitotic nuclear envelope disassembly (GO:0007077) | 2.75824222 |
| 64 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.73324440 |
| 65 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.72399616 |
| 66 | regulation of vitamin metabolic process (GO:0030656) | 2.70938268 |
| 67 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69482402 |
| 68 | regulation of ligase activity (GO:0051340) | 2.69250228 |
| 69 | regulation of metalloenzyme activity (GO:0048552) | 2.67562583 |
| 70 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.66401123 |
| 71 | natural killer cell mediated immunity (GO:0002228) | 2.66401123 |
| 72 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.65908943 |
| 73 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.63209603 |
| 74 | response to X-ray (GO:0010165) | 2.61649988 |
| 75 | rRNA processing (GO:0006364) | 2.61506726 |
| 76 | regulation of translation in response to stress (GO:0043555) | 2.61383457 |
| 77 | membrane disassembly (GO:0030397) | 2.60544184 |
| 78 | nuclear envelope disassembly (GO:0051081) | 2.60544184 |
| 79 | cell cycle G1/S phase transition (GO:0044843) | 2.60337908 |
| 80 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.60337908 |
| 81 | protein localization to kinetochore (GO:0034501) | 2.58973068 |
| 82 | negative regulation of protein ubiquitination (GO:0031397) | 2.58592164 |
| 83 | purine nucleobase biosynthetic process (GO:0009113) | 2.57380089 |
| 84 | tRNA methylation (GO:0030488) | 2.51268787 |
| 85 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.51266802 |
| 86 | rRNA metabolic process (GO:0016072) | 2.50368707 |
| 87 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.50322018 |
| 88 | isotype switching (GO:0045190) | 2.50322018 |
| 89 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.50322018 |
| 90 | DNA strand elongation (GO:0022616) | 2.49800656 |
| 91 | nucleobase biosynthetic process (GO:0046112) | 2.47518072 |
| 92 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.46205038 |
| 93 | mitochondrial RNA metabolic process (GO:0000959) | 2.45661234 |
| 94 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.45267075 |
| 95 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.42255399 |
| 96 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.42244716 |
| 97 | termination of RNA polymerase I transcription (GO:0006363) | 2.39483151 |
| 98 | mitochondrial DNA replication (GO:0006264) | 2.36833726 |
| 99 | intestinal epithelial cell development (GO:0060576) | 2.36722571 |
| 100 | de novo protein folding (GO:0006458) | 2.36172345 |
BZW1P2 
